DOSSIER · 13F-HR · Q1 2026

Decheng Capital LLC

Decheng's family office based in Greenwich, CT — $661M in tracked AUM across 14 positions as of Q1 2026.

D

Decheng·Greenwich, CT·Family Office

CIK 0002010850 · last filed Mar 31, 2026

Total AUM

$661M

▼ 5.5%

vs prior

Holdings

14

—

positions

Whale Score

75

75

strong

Activity

—

no data

changes this Q

Top sector

Health Care

42% weight

concentration

AI Analysis · Q1 2026 · Q1 2026

Portfolio Overview

Decheng Capital LLC’s 13F filing for the period ending September 30, 2025, reveals a concentrated portfolio focused on the biotechnology and healthcare sectors. The firm manages a total portfolio value of approximately $255.92 million across 16 holdings. This represents a significant reduction in capital deployment, with the total portfolio value decreasing by 35.4% from the previous quarter's $395.97 million.

The portfolio is characterized by high conviction, with the t...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

01

CG ONCOLOGY INC

$431M6.4M65.2%

02

Nuvation Bio Inc.

$111M26.0M16.8%

03

Upstream Bio Inc.

$25M2.7M3.7%

04

Aclaris Therapeutics, Inc.

$15M4.0M2.3%

05

AARDVARK THERAPEUTICS INC

$15M3.9M2.2%

06

Lyell Immunopharma, Inc.

$14M692K2.1%

07

NEWAMSTERDAM PHARMA CO NV

$10M325K1.6%

08

Arcus Biosciences, Inc

$10M478K1.6%

09

REVOLUTION MEDICINES INC(NSM)

$9M94K1.4%

10

Equillium Inc.

$9M4.4M1.3%

Filing history

Filing history loading…